An independent resource on Texas ibogaine research and policy. Gulf Docket explains the evolving Texas ibogaine research pathway, including public funding, federal constraints, safety questions, and trial milestones. We focus on clarity of sources, regulatory context, and what developments mean for Texans and stakeholders.
Quiet Harbor 52 exists to provide clear, evidence-first context about policy and research developments related to ibogaine in Texas. We are organized to help readers understand timelines, regulatory milestones, and the difference between authorized research activities and routine clinical access.
Our editorial approach is plainspoken: distill source documents, summarize implications, and surface uncertainty so readers can assess next steps.
To see the editorial hub where topical resources and timelines are gathered, many readers start at the site front page and navigate from there; a concise pathway back to the main index is available inside the site navigation and within contextual pages like the services overview at our services overview where we describe research support and briefings.
We rely on primary records (public registries and agency filings), peer-reviewed literature, and official announcements to assemble timelines and summaries. When discussing regulatory or safety matters we reference authoritative sources so readers can verify details themselves.
For methodology examples and standards we cross-check items against registry entries and official guidance such as ClinicalTrials.gov entries (an established public registry) and other official agency notices — these practices align with widely used transparency standards at repositories like ClinicalTrials.gov and general reference frameworks such as the National Library of Medicine's guidance available through NIH / NLM.
Quiet Harbor 52 curates and summarizes developments across research authorizations, public funding notices, institutional review milestones, and high-level safety reporting. The site is structured so readers can move from timelines to explanatory pages and FAQs without losing sight of original sources.
We also maintain contextual links for readers interested in practice or program providers; for example, when readers follow regulatory or service-related threads we may link to external informational resources such as treatment provider listings. We do not endorse providers, and we prominently state that we are not a treatment clinic. For context on service models elsewhere, some readers examine operational pages like the provider directory at ibogaine treatment Florida profiles, which we reference strictly as an example of how services are described publicly in other jurisdictions.
We compare registry metadata (sponsor, dates, protocol titles) with funding notices and institutional announcements. When possible we link directly to the primary registry entry and to secondary corroborating documents such as institutional press releases or ethics committee statements; for standards on registries see the widely used guidance at ClinicalTrials.gov overview (Wikipedia).
No. Quiet Harbor 52 is an independent information resource and not a clinic, medical provider, or licensed treatment center. The content on this site is not medical or legal advice and should not be used as a substitute for professional consultation.
Timeline updates are published on topical pages and in annotated timeline posts. We sometimes reference external program descriptions to illustrate operational models; for example, informational provider listings such as those at ibogaine treatment provider pages in Florida are cited purely for structural comparison — not endorsement.
We maintain editorial independence through transparent sourcing and by avoiding financial relationships with service providers. Our principles prioritize clarity, evidence, and safety context so readers can interpret developments for themselves.
If you are looking for specific program descriptions or operational information, our services page outlines the types of briefing and research support we publish; visit our services summary at services and briefings for a concise list of offerings and formats.